Maze Therapeutics (MAZE) Stock Price & Analysis

MAZE$33.90-0.43 -1.25%
BiotechnologyGrowth Stock
Compare
Market cap$1.85BEnterprise value$1.96BRevenue (TTM)$20.00MMarket position—

Score

64
Neutral
Value
56
Quality
37
Growth
100

AI Analysis

Snapshot

Maze Therapeutics doesn’t screen as a clean setup today — Stocklytics 64/100 leaves more to prove. Under the hood: revenue compounding ~-100% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

56
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

37
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Maze Therapeutics, Inc. (MAZE) last printed $33.90. Equity value is $1.85B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2022202320242025
$0.00$0.00$167.5M$0.00

About

Company description is not on file.

Maze Therapeutics (MAZE) Stock Price & Analysis

MAZE price $33.90 -0.43 -1.25%

Ticker
MAZE
Price
$33.90
Change
-0.43 -1.25%
Market cap
$1.85B
Dividend yield
0.00%
Beta
2.03
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
56
Quality
37
Growth
100

Stocklytics score rationale: value 56, quality 37, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener